NCT00321074View on ClinicalTrials.gov

Tacrolimus and Daclizumab Versus Tacrolimus and Steroids in Liver Recipients Receiving Sub-optimal Grafts

PHASE3CompletedINTERVENTIONAL
Enrollment

101

Participants

Timeline

Start Date

May 31, 2005

Primary Completion Date

October 31, 2007

Study Completion Date

October 31, 2007

Conditions
LIVER TRANSPLANTATION
Interventions
DRUG

TACROLIMUS

Immunosuppression

Trial Locations (9)

10126

Torino

20122

Milan

20162

Milan

24122

Bergamo

33100

Udine

35128

Padua

40138

Bologna

00144

Roma

00161

Roma

Sponsors
All Listed Sponsors
lead

Astellas Pharma Inc

INDUSTRY

NCT00321074 - Tacrolimus and Daclizumab Versus Tacrolimus and Steroids in Liver Recipients Receiving Sub-optimal Grafts | Biotech Hunter | Biotech Hunter